Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Complete Genomics Careers
    Registered Vendor
    • Sep 2010
    • 12

    #1

    Sr. Algorithms Engineer (13-PD-106)

    Position Code: 13-PD-106
    Reports To: Manager of Assembly Software Group
    Department: Software


    Description

    Complete Genomics is seeking a talented software engineer to develop high performance algorithms and software for genome assembly in collaboration with domain experts and other members of the assembly team. A successful candidate will have expertise in software design and implementation with a focus on scale and performance.

    Complete Genomics offers high-throughput, cost-effective DNA sequencing of human genomes. Our combination of novel technology and a service-based business model creates unique opportunities for innovative software to impact disease research personalized medicine.

    Qualifications
    • Exceptional computational and analytic abilities, with demonstrated experience solving large scale programming problems.
    • Expertise in the areas of genome assembly, reassembly, variant calling, and bioinformatics desired (but not required). Applicants who lack this experience should have a strong desire to learn.
    • Strong algorithm and implementation skills. Prior experience with C/C++, network & distributed computing, and Linux/Unix environments.
    • High level of expertise in graph algorithms, optimization, and statistical analysis.
    • 6+ years of experience designing and developing software, including at least 2 years of industry (or equivalent) experience.
    • Exemplary collaboration & communication skills.



    APPLY HERE


    Complete Genomics does not accept unsolicited agency resumes. Please do not forward unsolicited agency resumes to our website, employees or Human Resources.

    Complete Genomics will not pay fees to any third party agency or firm and will not be responsible for any agency fees associated with unsolicited resumes. Unsolicited resumes received will be considered property of Complete Genomics and will be processed accordingly without fee.

    Complete Genomics has the sole discretion to determine with whom we will enter into a contract. If you wish to work with Complete Genomics, please contact the Human Resources department directly.


    Complete Genomics is proud to be an equal opportunity employer

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...